InvestorsHub Logo
Followers 218
Posts 38765
Boards Moderated 0
Alias Born 04/29/2008

Re: Value_Investor post# 316

Friday, 08/26/2016 11:41:28 AM

Friday, August 26, 2016 11:41:28 AM

Post# of 430
Once the merger goes through, it will be just like any other biotech with a modest amount of cash and an drug candidate in early stages.

Before CYBL's drug trials failed, it was at $9/share. It then fell to $2.50 before crashing to 50 cents when they announced the merger.

It is not the safest or surest investment on the Nasdaq by a long stretch.

TA - Over $500 million in toxic funded pump and dumps exposed and growing every day!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KALV News